The Federal Register Vol. 82, Number 120 (Friday, June 23, 2017) published a notice on pages 28645-28646 extending the Cancer Immunotherapy Pilot Program "which permits patent applications pertaining to cancer immunotherapy to be advanced out of turn for examination and reviewed earlier (accorded special status)."